The next generation of automated microarray platforms for a multiplexed CYP2D6 assay

Biochips as Pathways to Drug Discovery

Volumn , Issue , 2006, Pages 97-108

  Kim, Phillip ^a   Fu, Yung Kang Ken ^a   Mahant, Vijay ^a   Kureshy, Fareed ^a   Hardiman, Gary ^b   Corbeil, Jacques ^c  

^a AutoGenomics   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845885480     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (12)

1. Goldstein, D.B. Pharmacogenetics in the laboratory and the clinic. N Engl J Med 348: 553-556, 2003.
2. Mancinelli, L., Croni, M., and Sadee, W. Pharmacogenomics: the promise of personalized medicine. AAPS PharmSci 2(1): 1-13, 2000.
3. Nebert, D.W. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet 60: 265-271, 1997.
4. Daly, A.K., Brockmoller, J., Broly, F., Eichelbaum, M., Evans, W.E., Gonzalez, F.J., Huang, J.D., Idle, J.R., Ingelman-Sundberg, M., Ishizaki, T., Jacqz-Aigrain, E., Meyer, U.A., Nebert, D.W., Steen, V.M., Wolf, C.R., Zanger, U.M. Nomenclature for human CYP2D6 alleles. Pharmacogenetics 6: 193-201, 1996.
5. Bertilsson, L., Dahl, M.L., Dalen, P., Al-Shurbaji, A. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol. 53(2): 111-122, 2002.
6. Gaedigk, A., Blum, M., Gaedigk, R., Eichelbaum, M., Meyer, U.A. Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am J Hum Genet. 48(5): 943-950, 1991.
7. Kimura, S., Umeno, M., Skoda, R.C., Meyer, U.A., Gonzalez, F.J. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet. 45(6): 889-904, 1989.
8. Kitada, M. Genetic polymorphism of cytochrome P450 enzymes in Asian populations: focus on CYP2D6. Int J Clin Pharmacol Res. 23(1): 31-35, 2003.
9. Mancinelli, L., Cronin, M., Sadee, W. Pharmacogenomics: the promise of personalized medicine. AAPS PharmSci. 2(1): E4, 2000.
10. Cascorbi, I. Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication. Eur J Clin Invest. 33(Suppl. 2): 17-22, November 2003.
11. Bayer, E.A. and Wilchek, M. The use of the avidin-biotin complex ASA tool in molecular biology. Methods Biochem Anal. 26: 1-45, 1980.
12. Schena, M., Heller, R.A., Theriault, T.P., Konrad, K., Lachenmeier, E., and Davis, R.W. Microarrays: biotechnology’s discovery platform for functional genomics. Trends Biotechnol. 16: 301-306, 1998.